DrugPatentWatch Database Preview
Profile for Denmark Patent: 1863839
» See Plans and Pricing
US Patent Family Members and Approved Drugs for Denmark Patent: 1863839
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Jan 29, 2029 | Novo | OZEMPIC | semaglutide |
Start Trial | Jan 29, 2029 | Novo | RYBELSUS | semaglutide |
Start Trial | Mar 20, 2026 | Novo | OZEMPIC | semaglutide |
Start Trial | Mar 20, 2026 | Novo | RYBELSUS | semaglutide |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |